Status:
COMPLETED
European Mortality & Length Of Intensive Care Unit (ICU) Stay Evaluation (ELOISE)
Lead Sponsor:
Università degli Studi di Ferrara
Collaborating Sponsors:
University Hospital of Ferrara
European Society of Intensive Care Medicine
Conditions:
Critical Illness
Eligibility:
All Genders
16+ years
Brief Summary
The starting point of ELOISE is the significant number of Intensive Care Unit (ICU) survivors who die after the transfer to ward. This mortality rate nullifies the sophisticated diagnostics and the li...
Detailed Description
Despite the high cost of Intensive Care Unit (ICU), a significant number of patients surviving intensive care die subsequently in hospital after the transfer to ward. Mortality rates after discharge f...
Eligibility Criteria
Inclusion
- admission to one of the Study Unit
- any organ support allowed
- age of at least 16 years
Exclusion
- age lower than 16 years
- patients admitted as donor for transplant
- patients admitted with limitation of care stated before admission
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
6433 Patients enrolled
Trial Details
Trial ID
NCT01422070
Start Date
November 1 2011
End Date
June 1 2012
Last Update
August 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maurizia Capuzzo
Ferrara, Italy, 44121